Literature DB >> 2037544

Quality control guidelines for Haemophilus test medium MIC susceptibility tests with cefmetazole, cefpodoxime, CI-960 (PD127391, AM-1090), and RU29246.

R N Jones, J A Washington, M A Pfaller, F P Koontz, E H Gerlach, M E Erwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2037544     DOI： 10.1093/jac/27.3.390

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Biographical Feature: Franklin P. Koontz, Ph.D., D(ABMM), F(AAM).

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

2.  Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.

Authors:  M J Bale; R N Jones
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.

Authors:  M S Barrett; R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

4.  Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.

Authors:  K W Yu; N X Chin; H C Neu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.